Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Ally Bridge Group (NY) LLC Stock Portfolio

$167Million– No. of Holdings #25

Ally Bridge Group (NY) LLC Performance:
2024 Q2: 3.34%YTD: 16.48%2023: 23.22%

Performance for 2024 Q2 is 3.34%, and YTD is 16.48%, and 2023 is 23.22%.

About Ally Bridge Group (NY) LLC and 13F Hedge Fund Stock Holdings

Ally Bridge Group (NY) LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $146.7 Millions. In it's latest 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $167.9 Millions as of 30 Jun, 2024.

The top stock holdings of Ally Bridge Group (NY) LLC are SLNO, SRPT, GERN. The fund has invested 7% of it's portfolio in SOLENO THERAPEUTICS INC and 6.9% of portfolio in SAREPTA THERAPEUTICS INC.

The fund managers got completely rid off VERONA PHARMA PLC (VRNA), AVADEL PHARMACEUTICALS PLC (AVDL) and DIANTHUS THERAPEUTICS INC stocks. They significantly reduced their stock positions in BLUEPRINT MEDICINES CORP (BPMC), INSMED INC (INSM) and CG ONCOLOGY INC. Ally Bridge Group (NY) LLC opened new stock positions in SAREPTA THERAPEUTICS INC (SRPT), LEGEND BIOTECH CORP and DAY ONE BIOPHARMACEUTICALS I (DAWN). The fund showed a lot of confidence in some stocks as they added substantially to CONTEXT THERAPEUTICS INC (CNTX).
Ally Bridge Group (NY) LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024

Ally Bridge Group (NY) LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Ally Bridge Group (NY) LLC made a return of 3.34% in the last quarter. In trailing 12 months, it's portfolio return was 44.01%.

New Buys

Ticker$ Bought
sarepta therapeutics inc11,613,000
legend biotech corp8,636,550
alumis inc8,229,380
disc medicine inc 7,504,160
day one biopharmaceuticals i7,387,390
avadel pharmaceuticals plc6,049,240
trevi therapeutics inc 4,395,280
tyra biosciences inc4,231,910

New stocks bought by Ally Bridge Group (NY) LLC

Additions


Additions to existing portfolio by Ally Bridge Group (NY) LLC

Reductions

Ticker% Reduced
blueprint medicines corp-53.01
insmed inc-48.4
cg oncology inc-45.42
xenon pharmaceuticals inc-45.25
merus n v-31.68
jasper therapeutics inc-24.6
longboard pharmaceuticals in-19.06
kura oncology inc-15.97

Ally Bridge Group (NY) LLC reduced stake in above stock

Sold off

Ticker$ Sold
lyra therapeutics inc-6,243,270
mersana therapeutics inc-3,590,440
verona pharma plc-11,854,100
olema pharmaceuticals inc-6,328,280
avadel pharmaceuticals plc-9,239,440
rapt therapeutics inc-3,771,600
marinus pharmaceuticals inc-3,568,750
dianthus therapeutics inc-6,509,040

Ally Bridge Group (NY) LLC got rid off the above stocks

Sector Distribution

Ally Bridge Group (NY) LLC has about 76.2% of it's holdings in Healthcare sector.

Sector%
Healthcare76.2
Others23.8

Market Cap. Distribution

Ally Bridge Group (NY) LLC has about 12.1% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP31.4
UNALLOCATED23.8
MID-CAP21.9
LARGE-CAP12.1
MICRO-CAP9.9

Stocks belong to which Index?

About 33.7% of the stocks held by Ally Bridge Group (NY) LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others66.3
RUSSELL 200033.7
Top 5 Winners (%)%
INSM
insmed inc
74.9 %
GERN
geron corp
28.4 %
SRPT
sarepta therapeutics inc
23.5 %
MRUS
merus n v
22.6 %
CNTX
context therapeutics inc
19.9 %
Top 5 Winners ($)$
INSM
insmed inc
5.1 M
MRUS
merus n v
2.6 M
GERN
geron corp
2.6 M
SRPT
sarepta therapeutics inc
2.2 M
BPMC
blueprint medicines corp
1.7 M
Top 5 Losers (%)%
PRAX
praxis precision medicines i
-31.9 %
MNMD
mind medicine mindmed inc
-22.8 %
JSPR
jasper therapeutics inc
-21.7 %
PMN
promis neurosciences inc
-21.5 %
BDTX
black diamond therapeutics i
-10.6 %
Top 5 Losers ($)$
PRAX
praxis precision medicines i
-3.1 M
MNMD
mind medicine mindmed inc
-2.1 M
JSPR
jasper therapeutics inc
-1.8 M
XENE
xenon pharmaceuticals inc
-1.1 M
SLNO
soleno therapeutics inc
-0.6 M

Ally Bridge Group (NY) LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Ally Bridge Group (NY) LLC

Ally Bridge Group (NY) LLC has 25 stocks in it's portfolio. About 55.9% of the portfolio is in top 10 stocks. PRAX proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Ally Bridge Group (NY) LLC last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions